{
    "name": "phenylephrine nasal",
    "comment": "OTC",
    "other_names": [
        "NeoSynephrine Nasal",
        "Neo-Synephrine Cold & Sinus Mild Strength Spray"
    ],
    "classes": [
        "Decongestants",
        "Intranasal"
    ],
    "source": "https://reference.medscape.com/drug/neosynephrine-phenylephrine-nasal-343410",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: not known if excreted in breast milk"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: not known if excreted in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to product or excipients",
                "Use for >3 days"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Rebound congestion may occur",
                "Temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur",
                "Use of container by more than one person may spread infection",
                "Use only as directed; frequent or prolonged use may cause nasal congestion to recur or worsen",
                "Ask a healthcare professional before in heart disease, high blood pressure, thyroid disease, diabetes, trouble urinating due to an enlarged prostate gland",
                "Stop use and ask healthcare professional if symptoms persist",
                "Stop use if symptoms persist"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "zavegepant intranasal",
            "description": {
                "common": "phenylephrine nasal will decrease the level or effect of zavegepant intranasal by  Other (see comment). Avoid or Use Alternate Drug. Avoid coadministration of intranasal decongestants with zavegepant intranasal. If unavoidable, administer intranasal decongestants at least 1 hr after zavegepant. "
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "nicotine intranasal",
            "description": {
                "common": "phenylephrine nasal decreases levels of nicotine intranasal by Other (see comment). Use Caution/Monitor. \nComment: Nasal vasoconstrictors prolong the time to peak concentrations by ~40% and decreases peak concentration by ~20%."
            }
        },
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "safinamide",
            "description": {
                "common": "phenylephrine nasal and safinamide both increase  sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Monitor patients for hypertension if safinamide is prescribed concomitantly with prescription or nonprescription sympathomimetics, including nasal, oral, or ophthalmic decongestants and cold remedies."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Stinging",
            "percent": null
        },
        {
            "name": "Dryness",
            "percent": null
        },
        {
            "name": "Rebound congestion",
            "percent": null
        },
        {
            "name": "Sneezing",
            "percent": null
        },
        {
            "name": "Burning",
            "percent": null
        }
    ]
}